NCT06919081 - Secretome Clinical Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

March 15, 2026

Study Completion Date

June 15, 2026

Conditions

Persistent Corneal Epithelial DefectCorneal Epithelial Disorders

Interventions

DRUG

Allogeneic Bone-Marrow Derived Mesenchymal Stromal Cells Secretome

Eye Drops

OTHER

Vehicle Control

Eye Drops

Trial Locations (1)

RECRUITING

University of Illinois at Chicago, Chicago

All Listed Sponsors

collaborator

National Eye Institute (NEI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Illinois at Chicago

OTHER